Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. - Christine CW; Richardson RM; Van Laar A; Fine EM; Khwaja OS; Liang GS; Bankiewicz K; Larson PS (Neurology, 2022)